Geocann Logo_Full (002).png
Geocann and Pathway Health form a strategic partnership to supply VESIsorb® formulated medical cannabis products to leading retail pharmacy brands throughout Canada
January 27, 2021 09:45 ET | Geocann
FORT COLLINS, Colo., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Geocann is proud to announce a strategic partnership with Pathway Health Corp. (“PHC”) that will bring VESIsorb® formulated products to the...
Geocann reinforces its commitment to pioneering new clinical studies with the addition of internationally recognized medical researcher
November 12, 2020 11:10 ET | Geocann
FORT COLLINS, Colo., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce that Michael Davidson, M.D., has joined the company’s executive management team as Head of Innovation, Technology,...
Nestlé Health Science expands distribution of hemp products formulated with VESIsorb® into Europe under industry-leading brand, Pure Encapsulations®
September 11, 2020 08:45 ET | Geocann
FORT COLLINS, Colo., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Geocann and Nestlé Health Science are proud to announce the European launch of CBD (from broad spectrum hemp extract) soft gel formulations...
Geocann and Sunderstorm enter agreement to expand California leadership position across the U.S. with VESIsorb® formulated cannabis products
September 01, 2020 11:34 ET | Geocann
FORT COLLINS, Colo., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce a strategic partnership with Sunderstorm that will bring VESIsorb® formulated cannabis products to millions of...
Geocann inks supply and distribution agreement with Opticann, a new U.S.-based company founded by former MedReleaf executives
August 06, 2020 16:00 ET | Geocann
FORT COLLINS, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce a strategic partnership with Opticann Inc. (“Opticann”) that will bring VESIsorb® formulated hemp products into...
Geocann introduces the industry’s first 4-in-1 immunity support formulation utilizing the patented VESIsorb® drug delivery system
July 30, 2020 19:00 ET | Geocann
FORT COLLINS, Colo., July 30, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has commercialized the first oral dose application that overcomes the well-known bioavailability...
Geocann’s VESIsorb® cannabidiol formulation delivers superior pharmacokinetic performance in published study
April 14, 2020 12:00 ET | Geocann
FORT COLLINS, Colo., April 14, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the peer-reviewed journal, Molecules, has published the results of a double-blind, cross-over study...
Geocann is first-to-market introducing cannabigerol (CBG) formulations utilizing the VESIsorb® drug delivery system
August 23, 2019 11:00 ET | Geocann
FORT COLLINS, Colo., Aug. 23, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has successfully commercialized the first cannabigerol (CBG) soft gel products that utilize the...
Geocann Logo_Full (002).png
Geocann Appoints Medical and Scientific Advisory Board to Expand Its Leadership Position in Research and Innovation
July 25, 2019 19:00 ET | Geocann
FORT COLLINS, Colo., July 25, 2019 (GLOBE NEWSWIRE) -- Geocann has appointed the first members of its Medical and Scientific Advisory Board. They will play an integral role in clinical study design,...
Geocann Logo_Full (002).png
Geocann Launches Patent-Protected Cannabis Formulations For Rapid Uptake Edible and Beverage Products
July 23, 2019 17:30 ET | Geocann
FORT COLLINS, Colo., July 23, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has successfully commercialized a portfolio of food and beverage cannabis formulations that...